Needle-Exchange Program Curbed HIV Spread.
People in this program will get an HIV test, free condoms and usage of a regular source of health care, including referrals for drug addiction assessments and treatment that can detect other infectious illnesses, such as for example hepatitis, according to history details in the news release. Critics contend that needle-exchange programs encourage illegal drug make use of, but this study displays the advantages of such programs, the researchers said.. Needle-Exchange Program Curbed HIV Spread, Study Finds: – THURSDAY, Sept. 3, 2015 – – A needle-exchange plan in Washington, D.C., has prevented hundreds of new HIV attacks, a new study suggests. The program for injection drug users was launched in 2007, and it prevented an estimated 120 fresh cases of HIV infection and saved about $44 million in HIV treatment costs within two years, the researchers said.A phase 2 research of MK-1602 offers been finished and end of stage 2 discussions with FDA are planned prior to initiating phase 3. A phase 3 study is likely to begin in 2016. MK-8031, an oral small molecule antagonist for preventing migraines. A phase 2 study of MK-8031 is expected to begin in 2016. In July 2011, Merck announced that it acquired discontinued medical development of an earlier investigational oral CGRP antagonist, Telcagepant , after some patients showed proof liver toxicity.